Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | ME2 | P23368 | 1/20 | 0.43 |
| ▸ | ME1 | P48163 | 1/20 | 0.43 |
| ▸ | ME3 | Q16798 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319811 | 0.88 | ALDH1A1 (0.60) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL22213562 | 0.83 | EGFR (0.45) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL20370344 | 0.83 | ALDH1A1 (0.44) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL678459 | 0.81 | NCOA1 (0.62) | ALDH1A1CYP1A2BRD4 | |
| SCHEMBL9326151 | 0.80 | PDE4B (0.52) | ALDH1A1MEN1MAPK1KMT2APTGS2 | |
| SCHEMBL5793895 | 0.80 | PTGS2 (0.42) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL5001532 | 0.79 | NCOA1 (0.59) | CYP1A2BRD4 | |
| SCHEMBL3519376 | 0.76 | MAPK14 (0.41) | ALDH1A1PTGS1PTGS2KDM4EMAPT | |
| SCHEMBL28756264 | 0.76 | MT-CO2 (0.53) | ALDH1A1PTGS1PTGS2SLC6A3MAPT | |
| SCHEMBL5225774 | 0.76 | HTR2C (0.37) | ALDH1A1MEN1MAPK1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509418-B2 | Chromophoric compounds and UV-absorbing compositions | LYGG CORPORATION (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250270164-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | LYGG CORPORATION | 2025-08-28 | — | — | US | disclosed |
| US-11345652-B2 | Anticonvulsant compounds | OWEN-BARRY PHARMACEUTICALS (CA) | 2022-05-31 | — | — | US | disclosed |
| US-20210017116-A1 | ANTICONVULSANT COMPOUNDS | OWEN-BARRY PHARMACEUTICALS INC. (CA) | 2021-01-21 | — | — | US | disclosed |
| US-20200148623-A1 | ANTICONVULSANT COMPOUNDS | OWEN-BARRY PHARMACEUTICALS INC. (CA) | 2020-05-14 | — | — | US | disclosed |
| US-10556853-B2 | Anticonvulsant compounds | OWEN-BARRY PHARMACEUTICALS INC. (CA) | 2020-02-11 | — | — | US | disclosed |
| WO-2018129609-A1 | ANTICONVULSANT COMPOUNDS | OWEN-BARRY PHARMACEUTICALS INC. (CA) | 2018-07-19 | — | — | WO | disclosed |
| US-20180194715-A1 | ANTICONVULSANT COMPOUNDS | OWEN-BARRY PHARMACEUTICALS INC. (CA) | 2018-07-12 | — | — | US | disclosed |
| US-20180194715-A1 | ANTICONVULSANT COMPOUNDS | OWEN-BARRY PHARMACEUTICALS INC. (CA) | 2018-07-12 | — | — | US | disclosed |
| US-20090298898-A1 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES | SYNGENTA CROP PROTECTION, INC. (US) | 2009-12-03 | — | — | US | disclosed |
| US-7569727-B2 | N-{(4-{3-[2,6-dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-[(E)-ethoxyimino]-methyl}-2,2,2-trifluoroacetamide; exhibit valuable preventive and/or curative activity even at low rates of concentration, while being well tolerated by warm-blooded animals, fish and plants | SYNGENTA CROP PROTECTION, INC. (US) | 2009-08-04 | — | — | US | disclosed |
| EP-2080752-A1 | Pesticidally active ketone and oxime derivatives | Syngenta Participations AG (CH) | 2009-07-22 | — | — | EP | disclosed |
| US-20080200525-A1 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES | SYNGENTA CROP PROTECTION, INC. (US) | 2008-08-21 | — | — | US | disclosed |
| US-20060128670-A1 | Pesticidally active ketone and oxime derivatives | SYNGENTA CROP PROTECTION, INC. | 2006-06-15 | — | — | US | disclosed |
| EP-0982026-B1 | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | HOFFMANN LA ROCHE (CH) | 2006-05-17 | — | — | EP | disclosed |
| EP-1638924-A1 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES | Syngenta Participations AG (CH) | 2006-03-29 | — | — | EP | disclosed |
| WO-2004113273-A1 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-12-29 | — | — | WO | disclosed |
| US-6184236-B1 | Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative | HOFFMANN-LA ROCHE INC. | 2001-02-06 | — | — | US | disclosed |
| EP-0982026-A2 | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998031697-A1 | ARYL C-GLYCOSIDE COMPOUNDS AND SULFATED ESTERS THEREOF | SANKYO COMPANY, LIMITED (JP) | 1998-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270164-A1 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | ERCC1, TYR, ERCC5 | ALDH1A1 1196/4885MEN1 1001/4885MAPK1 3325/4885 |
| US-20090298898-A1 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES | CHRM2, FOXO3, CHRM1 | ALDH1A1 1934/4885MEN1 1164/4885MAPK1 1933/4885 |
| US-12509418-B2 | Chromophoric compounds and UV-absorbing compositions | LBR, ERCC1, MC1R | ALDH1A1 1591/4885MEN1 4477/4885MAPK1 4024/4885 |
| US-20180194715-A1 | ANTICONVULSANT COMPOUNDS | GABRE, CACNA1B, GRIK5 | ALDH1A1 1140/4885MEN1 4075/4885MAPK1 3911/4885 |
| US-20210017116-A1 | ANTICONVULSANT COMPOUNDS | GABRE, CACNA1B, GRIK5 | ALDH1A1 1140/4885MEN1 4075/4885MAPK1 3911/4885 |
| US-20200148623-A1 | ANTICONVULSANT COMPOUNDS | GABRE, CACNA1B, GRIK5 | ALDH1A1 1140/4885MEN1 4075/4885MAPK1 3911/4885 |
| US-11345652-B2 | Anticonvulsant compounds | GABRE, CACNA1B, GRIK5 | ALDH1A1 1140/4885MEN1 4075/4885MAPK1 3911/4885 |
| US-20060128670-A1 | Pesticidally active ketone and oxime derivatives | CHRM2, CHRM1, DDT | ALDH1A1 1617/4885MEN1 738/4885MAPK1 2073/4885 |
| US-20080200525-A1 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES | CHRM2, FOXO3, CHRM1 | ALDH1A1 1934/4885MEN1 1164/4885MAPK1 1933/4885 |
| US-10556853-B2 | Anticonvulsant compounds | GABRE, CACNA1B, GRIK5 | ALDH1A1 1140/4885MEN1 4075/4885MAPK1 3911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.